Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private

BSE2040.2520 (+0.99 %)

PREV CLOSE ( ) 2020.25

OPEN PRICE ( ) 2059.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 15842

TODAY'S LOW / HIGH ( )2021.55 2059.70

52 WK LOW / HIGH ( )1909.9 2726.75

NSE2038.8014.8 (+0.73 %)

PREV CLOSE( ) 2024.00

OPEN PRICE ( ) 2038.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 2038.80 (3)

VOLUME 542413

TODAY'S LOW / HIGH( ) 2020.30 2052.60

52 WK LOW / HIGH ( )1909.7 2716.5

Chairman	Ramesh Juneja
Managing Director	Rajeev Juneja
Company Secretary	Hitesh Kumar Jain
Non Executive Independent Director	T P Ostwal Vijaya Sampath Bharat Anand Vivek Kalra
Whole Time Director	Sheetal Arora Satish Kumar Sharma

Incorporation Year : 03-07 1991

Registered Office :

Address : 208,Okhla Industrial Estate,Phase - 111 New Delhi,
Delhi-110020 .

Phone : 011-46846700 / 47476600

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE